Let’s get functional: drug sensitivity profiling to enable precision sarcoma medicine
Drug sensitivity profiling in patient-derived tumor models offers new hope for improving outcomes in cancers lacking effective therapies. Al Shihabi et al.1 demonstrate that short-term cultures from bone and soft tissue sarcomas enable clinically meaningful screening of multiple drugs and combinatio...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
3 October 2024
|
| In: |
Cell stem cell
Year: 2024, Volume: 31, Issue: 10, Pages: 1389-1390 |
| ISSN: | 1875-9777 |
| DOI: | 10.1016/j.stem.2024.09.006 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.stem.2024.09.006 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1934590924003205 
|
| Author Notes: | Claudia R. Ball, Stefan Fröhling |
| Summary: | Drug sensitivity profiling in patient-derived tumor models offers new hope for improving outcomes in cancers lacking effective therapies. Al Shihabi et al.1 demonstrate that short-term cultures from bone and soft tissue sarcomas enable clinically meaningful screening of multiple drugs and combinations, marking a significant advance in personalized care for these high-risk diseases. |
|---|---|
| Item Description: | Gesehen am 10.12.2025 |
| Physical Description: | Online Resource |
| ISSN: | 1875-9777 |
| DOI: | 10.1016/j.stem.2024.09.006 |